International Isotopes Inc. and Phantech Medical Team Up for PhanQual
International Isotopes, Inc. (INIS) has joined forces with Phantech Medical to launch a new joint venture called PhanQual. This collaboration is set to revolutionize the creation of durable calibration and reference sources tailored for pre-clinical imaging applications.
Partnership Overview
Phantech Medical is an innovative biomedical hardware company dedicated to improving the medical imaging field through its cutting-edge phantom technology. By refining and standardizing quantitative and quality management processes, Phantech aims to significantly boost the accuracy of medical imaging.
Since its founding in 2001, INIS has positioned itself as a leader in the calibration and reference source market. Through its subsidiary, RadQual, the company has successfully designed and distributed these essential resources for a variety of applications, serving both medical and research sectors globally.
Goals of PhanQual
PhanQual is set to combine advanced technologies and expertise from both INIS and Phantech. This venture will focus on developing innovative sealed source calibration devices, enhancing the tools available for research and theranostics communities. Additionally, RadQual will distribute the full range of Phantech's fillable sources through its extensive global distribution networks, increasing accessibility.
Perspectives from Company Leaders
Justin Jeffery, Co-Founder and Head of R&D at Phantech, emphasizes the nearly 30 years of experience INIS brings to the medical imaging sector, pointing out the shared mission of both companies. He notes, "The common goal of improving accuracy in nuclear medicine imaging is what makes this partnership so exciting. With INIS's strong expertise in manufacturing and distribution, we are optimistic about maximizing the impact of our innovative technologies."
On the other hand, Shahe Bagerdjian, President and CEO of International Isotopes, expresses enthusiasm about entering the pre-clinical space to become a leading global provider of calibration sources. He elaborates that the partnership with Phantech represents a natural evolution, aimed at utilizing advanced manufacturing techniques, including additive manufacturing and artificial intelligence.
About Phantech
Founded in 2018 in the USA, Phantech is committed to designing and manufacturing medical theranostic phantoms suitable for various imaging modalities. Their recent collaboration with Gremse-IT GmbH aims to enhance automation in analyzing their innovative nuclear medicine phantoms, paving the way for the new PhanQual product line.
About International Isotopes Inc.
Established in 1995, International Isotopes Inc. specializes in producing a diverse range of radioisotope-based products. They manufacture generic sodium iodide I-131 radiopharmaceuticals and provide calibration standards for nuclear pharmacies. Recently, they have embarked on a manufacturing joint venture to expand their market reach into China.
Conclusion
The partnership between International Isotopes Inc. and Phantech Medical holds great promise for the future. By combining their expertise and resources to develop the PhanQual series, they are set to make significant advancements in pre-clinical imaging calibration sources, ultimately leading to improved accuracy and efficiency in medical imaging practices.
Frequently Asked Questions
What is PhanQual?
PhanQual is a joint venture between International Isotopes Inc. and Phantech Medical focused on developing long-lasting calibration sources for pre-clinical imaging.
What technologies will PhanQual leverage?
PhanQual will utilize technologies from both INIS and Phantech, including patented fillable calibration source technology to enhance medical imaging.
When was International Isotopes Inc. founded?
International Isotopes Inc. was founded in 1995 and has established a strong reputation in the manufacturing of radioisotope products since then.
What is the focus of Phantech Medical?
Phantech Medical is dedicated to improving medical imaging performance through innovative phantom technologies designed for various diagnostic applications.
How will RadQual contribute to this partnership?
RadQual will distribute the fillable sources developed by Phantech on a global scale, ensuring they are accessible to a wide market and enhancing research capabilities.
